<DOC>
	<DOCNO>NCT00210613</DOCNO>
	<brief_summary>The primary purpose study ass possible withdrawal effect abruptly stop daily therapy dapoxetine compare continue daily therapy men premature ejaculation ( PE ) .</brief_summary>
	<brief_title>A Study Withdrawal Effects With Dapoxetine Treatment Premature Ejaculation</brief_title>
	<detailed_description>Premature ejaculation ( PE ) form male sexual dysfunction . A measure withdrawal effect associate stop therapy PE Discontinuation-Emergent Signs Symptoms ( DESS ) , series question sign symptom experience patient . This study men PE multicenter , randomize , double-blind trial consist 3 phase : pre-randomization phase ( screen visit 1-week baseline period ) ; 10-week double-blind treatment phase patient receive dapoxetine placebo ; 2-week follow-up phase . The total duration study approximately 13 week . During double-blind phase patient receive study medication daily treatment use `` as-needed '' basis prior sexual activity . After 9 week , patient ( half active patient ) continue treatment dapoxetine ( another half active patient ) switch placebo last week therapy , abruptly stop study drug . Assessments effectiveness include incidence withdrawal symptom , assess change DESS ; control ejaculation , satisfaction sexual intercourse , severity symptom impression , base question ask specified interval study . Safety assessment include incidence , severity , type adverse event throughout study , well laboratory test questionnaire monitor sexual function specify time study.The study hypothesis abruptly stop treatment dapoxetine men PE result increase withdrawal symptom ( assessed DESS ) , compare men stay treatment . Oral tablet dapoxetine ( 60 milligram ) take daily also need 10 week treatment . No 1 tablet daily treatment 1 as-needed tablet within 24-hour period .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>Patient stable , monogamous sexual relationship woman least 6 month plan maintain relationship duration study diagnosis premature ejaculation ( PE ) accord criterion Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) least 6 month study initiation experience PE majority sexual intercourse event good general health study initiation patient partner willing avoid situation activity may effect sexual activity ( example , avoid pregnancy , refrain preplanned surgery ) Not take dapoxetine participate another study investigate pharmacologic treatment PE within last 3 month history medical event surgery , injury , infection , neurological condition associate development PE take investigational drug within 1 month , use experimental medical device within 6 month , study initiation positive diagnosis depressive anxiety disorder , manic episode , panic disorder , obsessivecompulsive disorder , posttraumatic stress disorder , alcohol abuse dependence , schizophrenia , psychotic disorder know allergy hypersensitivity selective serotonin reuptake inhibitor ( SSRIs ) serotonin norepinephrine reuptake inhibitor ( SNRIs )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>dapoxetine</keyword>
	<keyword>premature ejaculation</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>orgasmic disorder</keyword>
	<keyword>sexual intercourse</keyword>
	<keyword>ejaculation</keyword>
</DOC>